Advertisement

Topics

Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry

12:13 EDT 17 May 2011 |

Merck isn’t messing around with its new hepatitis C drug. It has now enlisted a powerhouse partner in its bid to fight for market share against Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: VRTX). The Whitehouse Station, NJ-based pharma giant (NYSE: MRK) said today that it has formed a non-exclusive alliance with Roche’s Genentech unit to help [...]

Original Article: Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry

NEXT ARTICLE

More From BioPortfolio on "Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...